The neurotrophin-receptor code is specific: NGF-TrkA for nociceptive fibers, BDNF/NT-4-TrkB for mechanoreceptors, and NT-3-TrkC for large-diameter sensory and motor neurons (Huang & Reichardt, 2001). After nerve injury, Schwann cells upregulate NGF mRNA 100-fold within days, creating a gradient that guides TrkA-expressing axons toward distal targets (Heumann et al., 1987).

A critical discovery is that neurotrophins trigger axon growth through local protein synthesis at the axon tip. When NGF binds TrkA, it activates mTOR and MAPK pathways locally, driving translation of growth-associated proteins like GAP-43 (Verma et al., 2005). Axons respond to guidance cues in real-time without waiting for signals to reach the soma.

Schwann cells produce neurotrophins during repair, but long-term axon maintenance requires target-derived factors. If motor axons innervate sensory receptors, they do not receive correct neurotrophin support and eventually retract. Chen et al. (2024) showed misdirected axons in regenerated nerves have reduced receptor expression and smaller caliber.

The low-affinity receptor p75NTR adds complexity. It promotes survival with Trk co-expression but triggers apoptosis when expressed alone (Barker, 2004). After injury, p75NTR on Schwann cells helps clear myelin debris, but neuronal p75NTR can induce axon retraction if neurotrophin levels are insufficient.

Systemic neurotrophin administration has failed clinically due to side effects. The solution may be localized delivery from engineered nerve conduits that release specific neurotrophins in spatially defined patterns.

Testable predictions:

1. Gradient-based neurotrophin delivery improves target specificity over uniform delivery
2. Trk receptor expression profiling predicts which axon populations regenerate successfully
3. p75NTR blockade during early regeneration reduces competitive axon loss

Research synthesis via Aubrai.